Skip to main content

Massachusetts Trial Court


On March 24, 2022, the U.S. Attorney's Office for the District of Massachusetts entered into a settlement agreement with the Massachusetts Trial Court under Title II of the ADA to resolve its investigation of the public entity for discrimination against individuals with disabilities on the basis of Opioid Use Disorder (OUD). The agreement resolves a complaint filed with the U.S. Attorney’s Office that the Trial Court discriminated against drug court participants taking Medication for Opioid Use Disorder (MOUD). Under the terms of the agreement, all 25 of the Massachusetts drug courts will implement the Trial Court’s new policy in which only licensed prescribers or opioid treatment programs (OTP) will make decisions regarding a participant’s treatment plan, including the type of medication and dosage. Treatment plans will be developed by the licensed prescriber or OTP after conducting an individualized assessment for each participant.

Press Release

Case Open Date
Case Name
Massachusetts Trial Court
  • Criminal justice
  • law enforcement
  • Substance Use Disorder
Updated January 15, 2024